Preprint / Version 1

Effect of Periodontal Disease on Atherosclerotic Cardiovascular Disease (ASVD)


  • Satvik Desai none



ASCVD, Periodontitis, Dentistry, Medicine, Healthcare


Oral health has a strong connection to systemic health and thus it is important to research how periodontitis may lead to heart disease. Recent research has shown a positive correlation between periodontitis, or periodontal disease(PD), and congestive heart failure (CHF). Periodontal disease refers to the inflammation of the gingiva and the destruction of the maxillary and/or mandibular bone. Congestive heart failure occurs when blood flow towards the heart is restricted, resulting in a heart attack, and in most cases results in fatality. In an adult patient with periodontitis, there are several bacterial pathogens present in the oral cavity, such as P. gingivalis, T. forsythia, T. denticola, and A. Actinomycetemcomitans. These pathogens enter the bloodstream through the diseased area and have been known to cause a large assortment of health issues, one of which is Congestive Heart Failure. Risk factors for PD include smoking, poor oral home care, medications, and previous diagnosis of gingivitis. Risk factors for CHF include obesity, coronary artery disease (CAD)/atherosclerosis, hypertension, and diabetes. Reducing and controlling these risk factors can allow for a more comfortable and healthy quality of life. If periodontal disease is diagnosed and treated in its early stages, the risk of CHF may be reduced, and thus possibly reducing the prevalence of one of the biggest causes of hospitalization in the elderly population.


Ahn, J.-S., Yang, J. W., Oh, S.-J., Shin, Y. Y., Kang, M.-J., Park, H. R., Seo, Y., & Kim, H.-S. (2021). Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway. BMB Reports, 54(6), 323–328.

Armingohar, Z., Jørgensen, J. J., Kristoffersen, A. K., Abesha-Belay, E., & Olsen, I. (2014). Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. Journal of Oral Microbiology, 6(1), 23408.

Bale, B. F., Doneen, A. L., & Vigerust, D. J. (2016). High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Postgraduate Medical Journal, 93(1098), 215–220.

Beck, J., Garcia, R., Heiss, G., Vokonas, P. S., & Offenbacher, S. (1996). Periodontal disease and cardiovascular disease. Journal of Periodontology, 67(10 Suppl), 1123–1137.

Cairo, F., Gaeta, C., Dorigo, W., Oggioni, M. R., Pratesi, C., Pini Prato, G. P., & Pozzi, G. (2004). Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. Journal of Periodontal Research, 39(6), 442–446.

Fröhlich, H., Herrmann, K., Franke, J., Karimi, A., Täger, T., Cebola, R., Katus, H. A., Zugck, C., & Frankenstein, L. (2016). Periodontitis in Chronic Heart Failure. Texas Heart Institute Journal, 43(4), 297–304.

Galkina, E., & Ley, K. (2009). Immune and inflammatory mechanisms of atherosclerosis (*). Annual Review of Immunology, 27, 165–197.

Herath, T. D. K., Wang, Y., Seneviratne, C. J., Darveau, R. P., Wang, C.-Y., & Jin, L. (2013). The expression and regulation of matrix metalloproteinase-3 is critically modulated by Porphyromonas gingivalis lipopolysaccharide with heterogeneous lipid A structures in human gingival fibroblasts. BMC Microbiology, 13(1), 73.

Kawasaki, T., & Kawai, T. (2014). Toll-Like Receptor Signaling Pathways. Frontiers in Immunology, 5(461).

Kim, J., & Amar, S. (2006). Periodontal Disease and Systemic Conditions: a Bidirectional RelationshipD. Odontology, 94(1), 10–21.

Leiva, E., Wehinger, S., Guzmán, L., & Orrego, R. (2015). Role of Oxidized LDL in Atherosclerosis. Hypercholesterolemia, 1(1).

Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and Atherosclerosis. Circulation, 105(9), 1135–1143.

Molteni, M., Gemma, S., & Rossetti, C. (2016). The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators of Inflammation, 2016, 1–9.

Olsen, I., & Progulske-Fox, A. (2015). Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. Journal of Oral Microbiology, 7(1), 28788.

Rafieian-Kopaei, M., Setorki, M., Doudi, M., Baradaran, A., & Nasri, H. (2014). Atherosclerosis: process, indicators, risk factors and new hopes. International Journal of Preventive Medicine, 5(8), 927–946.

Sedghi, L. M., Bacino, M., & Kapila, Y. L. (2021). Periodontal Disease: The Good, The Bad, and The Unknown. Frontiers in Cellular and Infection Microbiology, 11.

Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L. (1998). Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 25(2), 134–144.

Van Dyke, T. E., & Sheilesh, D. (2005). Risk factors for periodontitis. Journal of the International Academy of Periodontology, 7(1), 3–7.

Xie, M., Tang, Q., Yu, S., Sun, J., Mei, F., Zhao, J., & Chen, L. (2020). Porphyromonas gingivalis disrupts vascular endothelial homeostasis in a TLR-NF-κB axis dependent manner. International Journal of Oral Science, 12(1).

Zardawi, F., Gul, S., Abdulkareem, A., Sha, A., & Yates, J. (2021). Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited. Frontiers in Cardiovascular Medicine, 7(15).

Zhou, J., & Windsor, L. J. (2006). Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases. Journal of Periodontal Research, 41(1), 47–54.